Urological cancer, Malmö
1 – 10 of 579
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Fosfomycin versus ciprofloxacin for transrectal prostate biopsy : An open randomised controlled multicentre drug trial
- Contribution to journal › Article
-
Mark
SPARC : The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
- Contribution to journal › Article
-
Mark
Peritoneal recurrence following nephrectomy for localized renal cancer : A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study–UroCCR 124)
- Contribution to journal › Article
-
Mark
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
- Contribution to journal › Article
-
Mark
Management of Lymph Node–Positive Renal Cell Carcinoma : Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
(2026) In European Urology
- Contribution to journal › Letter
-
Mark
Identifying Predictors of Delayed Ambulation After Minimally Invasive Gynecologic Oncology Surgery
- Contribution to journal › Article
-
Mark
Long-Term Outcomes After Laparoscopy-Assisted Cryoablation for Renal Cell Carcinoma-Results From a Single-Center Series
- Contribution to journal › Article
-
Mark
Age-Dependent Interplay of Modifiable Risk Factors and Genetic Risk in Pancreatic Cancer
- Contribution to journal › Article
-
Mark
Prognostic value of tumour volume based on [18F]PSMA-1007 PET/CT in prostate cancer
- Contribution to journal › Article
-
Mark
Factors associated with potentially inappropriate medication use, medication underuse and overuse in older adults in the German National Cohort
- Contribution to journal › Article
